Group items tagged

Aspen has committed not to charge more for its six generic cancer drugs for the next 10 years in the UK, according to the Competition and Markets Authority (CMA). The CMA also clarified that "although these commitments were offered while the UK was a part of the European Union" they remain "legally binding". It added: "The CMA has now assisted the NHS to secure binding undertakings from Aspen, under the law of England and Wales, which enshrine the UK elements of the commitments and are enforceable by UK courts, including in relation to the supply of these drugs in Northern Ireland and Scotland." This allows NHS to monitor and ensure compliance by Aspen following the UK's exit from the EU. In 2017, the European Commission began an investigation into Aspen over concerns that the company had engaged in excessive pricing for 6 off-patent cancer medicines.

An oral drug combination by Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial. In the mid-stage trial, 47 per cent of the patients that were given the two drugs Tafinlar and Mekinist saw their tumours shrink, far above a rate of 11 per cent in a comparative group of participants on standard chemotherapy, the drugmaker said on Monday, June 6. The participants, aged one to 17 years, were suffering from low-grade gliomas (LGG), the most common childhood brain cancer. The trial only included those who were found to have a mutation known as BRAF V600, a genetic contributor in about 15 per cent to 20 per cent of paediatric LGG cases. Among further results of the trial with 110 participants, the median time without disease progression was 20.1 months for those given the Novartis drug combo, compared to 7.4 months on chemotherapy. The new oral treatment candidate also caused less severe side effects than burdensome chemotherapy.

Morning friends,today i would like to stress on the importance of screening programmes for early detection of cervical cancer.Cervical cancer is perhaps the most common female genital tract cancer in the developing countries

Jual cytotec misoprostol jakarta misoprostolhotline : call 08574 0559 466. Jual Obat misoprostol Cytotec di Jakarta Bandung.Jogjakarta

MD Anderson Cancer Center and Ascentage Pharma entered into a five-year collaboration that aims to accelerate clinical development of novel apoptosis-targeted and tyrosine kinase inhibitor drug candidates for leukemia treatment. Read the complete report Click on http://bit.ly/2NIzta5

Living with diabetes can be managed by proper medication. However, you may have questions regarding the medications available to you. Here, we will take a closer look at two medications, Ozempic and Saxenda, so that you can see how these medications can impact your health. A CLOSER LOOK AT DIABETES Diabetes can be divided into two categories, type 1 diabetes (T1D) and type 2 diabetes (T2D). Type 1 diabetes is an autoimmune disorder and is commonly diagnosed in children. Individuals with T1D require lifelong insulin treatment to manage their diabetes. Type 2 diabetes is diagnosed later in life due to genetics, lifestyle, and other risk factors. Unlike T1D, there are numerous treatment options other than insulin therapy to manage type 2 diabetes. GLP-1 RECEPTOR AGONISTS A common drug class used to treat type 2 diabetes is glucagon-like peptide 1 (GLP-1) receptor agonists. GLP-1 receptor agonists work by lowering blood glucose and slowing gastric emptying. Benefits of using a GLP-1 receptor agonist include: weight loss, atherosclerotic cardiovascular disease (ASCVD) benefits, lowering A1C values, and chronic kidney disease (CKD) benefits with little risk of hypoglycemia. Common GLP-1 receptor agonist side effects include nausea, vomiting, diarrhea, weight loss, and injection site reactions. GLP-1 receptor agonists should not be used in patients with a personal or a family history of medullary thyroid cancer.

Buy Online Generic Xeloda 500mg and 150mg Tablets, After releasing the patent of manufacturing company Roche then many companies manufactures a generic version of Xeloda e.g. Natco Pharma manufactures #Capnat500mg, manufactures by Celon labs trade name is #Capcel500mg and many other. Indian Capecitabine is a type of chemotherapy called an anti-metabolite. The body changes capecitabine into a common chemotherapy drug called fluorouracil. #Xeloda500mg stops cells making and repairing DNA. Cancer cells need to make and repair DNA so they can grow and multiply. Purchase generic versions of #Capecitabine or its alternatives from MedsDots.com true Indian Pharmacy at cheap cost with quality assurance with guaranteed shipping in China, USA, Hong Kong, UK, Russia, Malaysia, Singapore, Cambodia, Vietnam, Nigeria, Hungary, Belarus, Philippines, UAE, Jordan, Finland, New Zealand and many other across the world. To know more details of Indian brand of Capecitabine You can contact us via QQ: 3451266709, call us at -> +91-9971646666, WeChat or Skype: medsdelta or email: medsdelta@gmail.com or visit us at www.medsdelta.com

Insomnia is one of the most common types of sleep disorders that affects the quality of sleep and makes it difficult for an individual to fall asleep at the desired time. People who suffer from this disorder feel tired and fatigued in the morning because they are not able to get a good and sound sleep. If you are experiencing severe symptoms of this disorder, it is recommended that you seek medical treatment by consulting your healthcare provider or doctor. Therefore, he can determine the root cause of your problem. Medical conditions such as heart disease, pain, cancer, or thyroid disorders can cause insomnia. Total sleep duration varies from person to person, but most adults need at least eight hours of sleep in a 24-hour period to feel active and refreshed. People suffering from this disorder can easily buy sleep aids, such as Temazepam 10mg, from trusted online pharmacies to reduce the symptoms associated with this sleep disorder. These drugs can be purchased online from Pharma Health Online.